About: Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy) Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2000 (uk) im Mai 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2000 (ast) scientific article published on 01 May 2000 (en)
publication date	wds:Q74136753-7A286444-AFEC-4FC6-A476-760C4BF40FDA
publication date	2000-05-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q74136753-984CE7BB-8534-439F-9054-754517004163
exact match	https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702351
author name string	wds:Q74136753-12D543E1-AED6-430A-BB53-F096E8B13595 wds:Q74136753-165CD979-E4D7-4EBB-BFA8-6ED6A9A9A611 wds:Q74136753-182B71B2-0405-4A26-B7C8-B1FF86343DD6 wds:Q74136753-18D60519-1E44-41B5-9D02-D2079EB0A325 wds:Q74136753-1FA583AF-3362-43E0-A61F-CA82D6FE2C2F wds:Q74136753-52BE5F86-5327-4787-9EE6-904AF45E89F7 wds:Q74136753-83275D60-B002-4493-B951-959434CA02D4 wds:Q74136753-B51FB1B8-BFEE-47AB-9A54-78FF32B2EFD5 wds:Q74136753-BBA75E28-3E01-4E20-A5CF-040679BC4A77 wds:Q74136753-E0F0F7B8-8DD6-4DEC-90CC-F11D58114E78 wds:Q74136753-F780F669-32A8-4600-8A26-E2C63298AA29
author name string	H Fernandez S J Forman K Blume J Gajewski S Tarantolo A Kashyap B S Andersson M Donato J Wingard W W Hu V Gian
rdfs:label	Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy) (en) Allogeneic stem cell transplantation (nl)
skos:prefLabel	Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy) (en) Allogeneic stem cell transplantation (nl)
name	Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy) (en) Allogeneic stem cell transplantation (nl)
author	wds:Q74136753-0DBD7A8F-A6FE-4F4D-B7B0-D99E32996497 wds:Q74136753-163D6AEA-AEF4-4CFA-B031-1CF61B6F8468
author	Sergio Giralt Richard E Champlin
title	wds:Q74136753-C45DAC89-0380-4DA9-B32E-1734B24CF291
title	Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy) (en)
page(s)	wds:Q74136753-DE8137F6-FA5B-4A5D-BE77-F23786B092AC
page(s)	S35-8
instance of	wds:Q74136753-FB16572B-68FE-454B-88D8-84DDC8A5C3A9
instance of	scholarly article
main subject	wds:Q74136753-7DDE87ED-DFB2-4E9B-93B0-97F22A1A1975
main subject	stem cell transplantation
PubMed ID	wds:Q74136753-7B10C44B-5214-4E32-81B1-A571DC181169
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10933185
PubMed ID	10933185
published in	wds:Q74136753-88F98A42-3C19-4431-9087-EC2DBE7AD298
published in	Bone Marrow Transplantation
volume	wds:Q74136753-8F32EE7C-8705-4ED7-A10D-8FCCFCC1FDA2
volume	25 Suppl 2
DOI	wds:Q74136753-E3AF826D-7BE1-41E1-AEE8-0E7F2552E4E9
DOI	http://dx.doi.org/10.1038/SJ.BMT.1702351
DOI	10.1038/SJ.BMT.1702351
Dimensions Publication ID	wds:Q74136753-A28D9049-3BA9-4776-8114-49BD85C82EF7
Dimensions Publication ID	1023445788
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74136753
is cites work of	Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and M Novel approaches to transplant conditioning Pharmacokinetics of intravenous busulfan in children prior to stem cell transplantation Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT. Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin's lymphoma. Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity Bone marrow transplantation for myelodysplastic syndrome--who? when? and which? Hematopoietic stem cell transplantation in Lebanon: first comprehensive report Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Plasma pharmacokinetics of high-dose oral busulfan in children and adults undergoing bone marrow transplantation Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome. Management of high-risk myelodysplastic syndromes Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan Once-daily i.v. BU-based conditioning regimen before allogeneic hematopoietic SCT: a study of influence of GST gene polymorphisms on BU pharmacokinetics and clinical outcomes in Chinese patients
is cites work of	wds:Q34299798-6114D57E-BB4B-4A0F-9AC2-541C49AEC413 wds:Q53038103-9BF90E33-710F-47BA-9E01-A4405A9D3D9D wds:Q37251071-9EF74553-8477-43B3-9ADF-3504513336E2 wds:Q44451164-82B21E44-CAB3-40BE-9D5A-884187BBA20A wds:Q90590301-A2A6F05E-33D4-4AC5-A6D1-212D071D5001 wds:Q46244551-316A4D04-AA9D-4E68-AF48-1C407C8257F4 wds:Q33978951-F83AF8A7-6EB8-4524-BFB8-D24C11E45D74 wds:Q36920394-A71A6C7A-E385-4477-BE94-AB384B8E7398 wds:Q44326450-780A421F-D44C-4B85-B318-BC5530613E75 wds:Q34803700-84C8A94F-EB66-44DB-AC5A-8A66DD33224B wds:Q34460655-C85114C9-AC0C-4BA6-A5F4-30AA7F7D7880 wds:Q43429437-62182923-CF96-450E-A568-28D329A8FEED wds:Q44351320-B32109BF-F900-4952-AC10-109B78FCB1AF wds:Q86852071-DDB8D165-3F1F-4C47-AE53-D0D1A035F5BA wds:Q41818881-1CC256B7-51BE-4E1A-AFC6-BF0940560141

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software